Antibody microarrays offer high-throughput immunoassays for multiplexed analyses of clinical samples. For such approaches, samples are either labeled in solution to enable a direct readout on the single binder assay format or detected by matched pairs of capture and detection antibodies in dual binder assay format, also known as sandwich assays. Aiming to benefit from the flexibility and capacity offered by single binder assay readout and the specificity and sensitivity of dual binder assays, we developed a multiplexed dual binder procedure that is based on a sequential, rather than combined, antigen binding. The method, entitled dual capture assay (DCA), is composed of an initial antigen capture by antibodies on beads, followed by labeling of captured protein targets on beads, combinatorial elution steps at high and low pH, and a readout using a secondary bead array. Compared to classical single binder assays, the described method demonstrated several advantages such as reduced contribution of off-target binding, lower noise levels, and improved correlation when comparing with clinical reference values. This procedure describes a novel and versatile immunoassay strategy for proteome profiling in body fluids.
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
We thank all members of the Biobank Profiling group at SciLifeLab, as well as the entire staff of the Human Protein Atlas. This study was funded by grants from Science for Life Laboratory, the Knut and Alice Wallenberg Foundation, and the KTH Center for Applied Proteomics (KCAP) funded by the Erling-Persson Family Foundation. The authors declare no conflict of interest.
Solier C, Langen H (2014) Antibody-based proteomics and biomarker research-current status and limitations. Proteomics 14:774–783CrossRefPubMedGoogle Scholar
Fu Q, Schoenhoff FS, Savage WJ, Zhang P, Van Eyk JE (2010) Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl 4:271–284CrossRefPubMedGoogle Scholar
Uhlen M, Fagerberg L, Hallstrom BM et al (2015) Tissue-based map of the human proteome. Science 347:1260419–1260419CrossRefPubMedGoogle Scholar
Ayoglu B, Haggmark A, Neiman M et al (2011) Systematic antibody and antigen-based proteomic profiling with microarrays. Expert Rev Mol Diagn 11:219–234CrossRefPubMedGoogle Scholar
Bystrom S, Ayoglu B, Haggmark A et al (2014) Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis. J Proteome Res 13:4607–4619CrossRefPubMedGoogle Scholar
Ayoglu B, Chaouch A, Lochmüller H et al (2014) Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies. EMBO Mol Med 6:918–936CrossRefPubMedPubMedCentralGoogle Scholar
Bachmann J, Burté F, Pramana S et al (2014) Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria. PLoS Pathog 10:e1004038CrossRefPubMedPubMedCentralGoogle Scholar
Landegren U, Vänelid J, Hammond M et al (2012) Opportunities for sensitive plasma proteome analysis. Anal Chem 84:1824–1830CrossRefPubMedGoogle Scholar